Key module genes in proximal tubular cells drive microenvironmental chronic inflammation and fibrosis in diabetic

Wenjing Zhou1, Zhaogui Chen1, Guanghui Ying1

  • 1Department of Nephrology, Beilun People's Hospital, Ningbo, 315826, Zhejiang, China.

Insights

Diabetic kidney disease involves dynamic changes in kidney proximal tubular cells. The RXRA-G6PC pathway offers a potential therapeutic target for this diabetes complication.

Area of Science:

  • Nephrology
  • Molecular Biology
  • Genomics

Background:

  • Diabetic kidney disease (DKD) is a severe diabetes complication.
  • Proximal tubular (PT) epithelial cells are crucial in DKD progression.
  • The dynamic molecular mechanisms of PT cells in DKD are not fully understood.

Purpose of the Study:

  • To analyze the heterogeneity and functional changes of PT epithelial cells in DKD.
  • To identify key molecular players and pathways involved in DKD pathogenesis.
  • To uncover potential therapeutic targets for DKD.

Main Methods:

  • Integration of single-cell and bulk RNA sequencing datasets (GSE183276, GSE30122).
  • Classification of PT epithelial cell subpopulations (PT-Homeostatic, PT-Transitional, PT-Stressed).
  • Functional enrichment analysis, pseudotime analysis, and in vitro experiments.

Main Results:

  • PT epithelial cells in DKD transition from homeostatic to stressed phenotypes.
  • PT-Homeostatic cells decrease, while PT-Transitional and PT-Stressed cells increase in DKD.
  • The RXRA-G6PC axis was identified as a key regulator, with its downregulation contributing to DKD progression.

Conclusions:

  • DKD involves a dynamic phenotypic shift in proximal tubular epithelial cells.
  • The RXRA-G6PC axis plays a critical role in regulating PT cell function and DKD pathogenesis.
  • Targeting the RXRA-G6PC axis presents a promising therapeutic strategy for diabetic kidney disease.

Related Concept Videos

Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...